Literature DB >> 11305722

Relationship of chromosome 21 and acute leukemia in children with Down syndrome.

J W Taub1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11305722     DOI： 10.1097/00043426-200103000-00012

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN： 1077-4114            Impact factor:   1.289


× No keyword cloud information.
  8 in total

1.  Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins.

Authors:  Terry S Elton; Sarah E Sansom; Mickey M Martin
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

2.  Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia.

Authors:  Yubin Ge; Alan A Dombkowski; Katherine M LaFiura; Dana Tatman; Ravikiran S Yedidi; Mark L Stout; Steven A Buck; Gita Massey; David L Becton; Howard J Weinstein; Yaddanapudi Ravindranath; Larry H Matherly; Jeffrey W Taub
Journal:  Blood       Date:  2005-10-25       Impact factor: 22.113

3.  Congenital abnormalities and acute leukemia among children with Down syndrome: a Children's Oncology Group study.

Authors:  Amy M Linabery; Cindy K Blair; Alan S Gamis; Andrew F Olshan; Nyla A Heerema; Julie A Ross
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09-30       Impact factor: 4.254

Review 4.  Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology.

Authors:  Ana C Xavier; Yubin Ge; Jeffrey W Taub
Journal:  J Mol Diagn       Date:  2009-09       Impact factor: 5.568

5.  The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy.

Authors:  Y Ge; K M LaFiura; A A Dombkowski; Q Chen; S G Payton; S A Buck; S Salagrama; A E Diakiw; L H Matherly; J W Taub
Journal:  Leukemia       Date:  2007-12-20       Impact factor: 11.528

6.  Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome.

Authors:  Diane C Cabelof; Hiral V Patel; Qing Chen; Holly van Remmen; Larry H Matherly; Yubin Ge; Jeffrey W Taub
Journal:  Blood       Date:  2009-07-24       Impact factor: 22.113

7.  A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.

Authors:  Ana C Xavier; Holly Edwards; Alan A Dombkowski; Tugce B Balci; Jason N Berman; Graham Dellaire; Chengzhi Xie; Steven A Buck; Larry H Matherly; Yubin Ge; Jeffrey W Taub
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

8.  Childhood and maternal infections and risk of acute leukaemia in children with Down syndrome: a report from the Children's Oncology Group.

Authors:  K N Canfield; L G Spector; L L Robison; D Lazovich; M Roesler; A F Olshan; F O Smith; N A Heerema; D R Barnard; C K Blair; J A Ross
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.